WOUND SEALING FILM
    22.
    发明申请

    公开(公告)号:US20230088196A1

    公开(公告)日:2023-03-23

    申请号:US17774792

    申请日:2020-11-11

    Abstract: This disclosure describes a wound sealing film containing a first layer having a first surface and a second surface, said first layer contains a first polymer composition, a second layer having a first surface and a second surface, said second layer contains an adhesive, and a third layer having a first surface and a second surface, said third layer contains a polymeric gel, wherein the second layer is positioned between the first layer and the third layer, method of making and using the wound sealing film. In some aspects, a wound sealing film can contain a first layer containing a first polymer composition, and a combined layer containing a polymeric gel and an adhesive.

    TISSUE INTERFACE FOR NEGATIVE PRESSURE AND INSTILLATION THERAPY

    公开(公告)号:US20230000688A1

    公开(公告)日:2023-01-05

    申请号:US17779792

    申请日:2020-12-03

    Abstract: Dressings, systems, and methods for treating a tissue site are described. The dressing includes a contact layer having a first side and a second side. The first side of the contact layer configured to be positioned adjacent to the tissue site. The contact layer has a plurality of holes extending through the contact layer from the first side to the second side. The dressing includes a cover layer having a first side and a second side. The first side of the cover layer is coupled to the contact layer. The dressing also includes at least one retainer layer removably coupled to the second side of the cover layer.

    SYSTEM AND METHODS FOR THE TREATMENT OF WOUNDS WITH NEGATIVE PRESSURE AND INSTILLATION OF PEROXIDE PYRUVIC ACID

    公开(公告)号:US20200306428A1

    公开(公告)日:2020-10-01

    申请号:US16822306

    申请日:2020-03-18

    Abstract: In one example embodiment, a system for treating a tissue site is disclosed comprising a dressing adapted to contact the tissue site and provide a fluid seal between a therapeutic environment and a local external environment, and a solution source fluidly coupled to the dressing and adapted to deliver an antimicrobial solution comprising a peroxy α-keto carboxylic acid, such as peroxy pyruvic acid, to the tissue interface. The system may further comprise a negative-pressure source fluidly coupled to the dressing and adapted to provide negative pressure to the therapeutic environment after delivery of the antimicrobial fluid to the therapeutic environment. In another example embodiment, a method for treating a tissue site is disclosed comprising positioning a tissue interface to contact the tissue site, covering the tissue interface and the tissue site with a drape to provide a fluid seal between the therapeutic environment and the local external environment, and delivering an antimicrobial solution comprising peroxy α-keto carboxylic acid to the therapeutic environment before providing negative pressure to the therapeutic environment.

    Delivery-And-Fluid-Storage Bridges For Use With Reduced-Pressure Systems

    公开(公告)号:US20190076586A1

    公开(公告)日:2019-03-14

    申请号:US16152188

    申请日:2018-10-04

    Abstract: Systems, methods, and apparatuses are presented that facilitate the provision of reduced pressure to a tissue site by using a delivery-and-fluid-storage bridge, which separates liquids and gases and provides a flow path for reduced pressure. In one instance, a delivery-and-fluid-storage bridge includes a delivery manifold for delivering reduced pressure to a treatment manifold at the tissue site and an absorbent layer proximate the delivery manifold adapted to receive and absorb liquids. The delivery manifold and the absorbent layer are encapsulated in an encapsulating pouch. A first aperture is formed proximate a first longitudinal end of the delivery-and-fluid-storage bridge for fluidly communicating reduced pressure to the delivery manifold from a reduced-pressure source, and a second aperture is formed on a patient-facing side of the delivery-and-fluid-storage bridge. Reduced pressure is transferred to the tissue site via the second aperture. Other systems, apparatuses, and methods are disclosed.

Patent Agency Ranking